Moreover, IL-6, IL-1β, AKT1, TNF-α, and MAPK3 may be the potential targets of geniposide.[65] However, the mechanisms underlying the effects of geniposide on inflammation and oxidative stress in COVID-19 and AS comorbidity have not been investigated. The gene discussed is MAPK3; the disease is COVID-19.